ZHANG Ming-yuan, CHANG Liang, LIU Chang-hai, CHEN Qiu-fen, ZHANG Jun-dong, LU Feng. An improvement method of pre-column derivatization LC-UV for assaying kanamycin in amikacin sulfate injection[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(5): 344-346. doi: 10.3969/j.issn.1006-0111.2013.05.006
Citation:
|
ZHANG Ming-yuan, CHANG Liang, LIU Chang-hai, CHEN Qiu-fen, ZHANG Jun-dong, LU Feng. An improvement method of pre-column derivatization LC-UV for assaying kanamycin in amikacin sulfate injection[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(5): 344-346. doi: 10.3969/j.issn.1006-0111.2013.05.006
|
An improvement method of pre-column derivatization LC-UV for assaying kanamycin in amikacin sulfate injection
- 1.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China
- 2.
Shanghai Sine Pharmaceutical Laboratories Co., Ltd, Shanghai 201206, China
- Received Date: 2012-12-17
- Rev Recd Date:
2013-04-08
-
Abstract
Objective To develop and evaluate the stable method for the determination of impurity D (kanamycin) in amikacin sulfate injection with pre-column derivatization HPLC. Methods The lower concentration of sample was used. An Agilent ZORBAX SB-C18 column(4.6 mmá150 mm, 5 μm) was used for the chromatographic separations. The mobile phase consisted of mixture of a 2.7% solution of potassium dihydrogen phosphate adjusted to pH 6.5 (using 22 g/L solution of potassium hydroxide) and methanol (30:70, v/v). The flow rate was 1 ml/min. A 50μl volume of each sample was injected. The column temperature was maintained at 30℃. Results The linear range of kanamycin was 2~80 μg/ml (r=0.999 8), accuracy was (93.08±9.65)%. Conclusions The development method was successfully applied to the quantitative determination of kanamycin in amikacin sulfate injection and also offered a new perspective for safety evaluation of amikacin sulfate injection.
-
References
[1]
|
Reynolds A, Hamilton-Miller J,Brumfitt W.Newer aminoglycosides-amikacin and tobramycin: An in vitro comparison with kanamycin and gentamicin[J].Brit Med J,1974,3(5934):778. |
[2]
|
Murillo-Cuesta S,Contreras J,Cediel R,et al.Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice[J].Lab Anim-uk,2010,44(2):124. |
[3]
|
Peloquin CA,Berning SE,Nitta AT,et al.Aminoglycoside toxicity:daily versus thrice-weekly dosing for treatment of mycobacterial diseases[J].Clin Infect Dis,2004,38(11):1538. |
[4]
|
Penha FM,Rodrigues EB,Maia M,et al.Retinal and ocular toxicity in ocular application of drugs and chemicals-part II:retinal Toxicity of current and new drugs[J].Ophthalmic Res,2010,44(4):205. |
[5]
|
Ovalles JF, Brunetto MR,Gallignani M.A new method for the analysis of amikacin using 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) derivatization and high-performance liquid chromatography with UV-detection[J].J Pharmaceut. Biomed.,2005,39(1):294. |
[6]
|
李 茜,刘 英,韩春霞,等. 离子色谱法测定硫酸阿米卡星原料及其制剂的有关物质[J]. 药物分析杂志,2012,32(2):318. |
[7]
|
陈冠华,潘淑萍,胡江宁. 硫酸阿米卡星含量及有关物质的HPLC-ELSD测定[J].中国医药工业杂志,2005,35(3):171. |
[8]
|
王明娟,胡昌勤,金少鸿.硫酸阿米卡星注射液及有关物质的HPLC法分析[J].中国抗生素杂志,2001,26(5):345. |
[9]
|
British Pharmacopoeia. 2010 Volume Ⅲ [S].2010. |
[10]
|
中国药典2010版二部[S]. 2010:984. |
-
-
Proportional views
-